The Effects of Olive Oil on Non-Alcoholic Fatty Liver Disease (NAFLD) in Male Wistar Rats
Abstract
Background and Aim: Non-alcoholic fatty liver disease (NAFLD) is a chronic condition associated with poor liver performance. No strategy for NAFLD treatment other than weight reduction and lifestyle modification, including diet, has yet been suggested. This study was performed to show the effect of olive oil on NAFLD improvement.Materials and Methods: In this trial, 35 male Wistar rats were fed a basic diet for 14 days, and then they received a high fat – high carbohydrate diet (43% fat, 50% carbohydrates and 17% protein) for 28 days to induce NAFLD. Afterwards, intervention period was started by dividing the animals into 3 groups as control (C) (induction diet), treatment 1 (T1) (10% olive oil) and treatment 2 (T2) (20% olive oil) for 28 days. Biochemical indices such as AST, ALT, TG, Total Cholesterol, HDL-C, and LDL-C were measured between each two periods. Twenty-four rats were included in the final analysis. Data were analyzed using ANCOVA and repeated measures tests.Results: Mean AST decreased in C group from 466 UI/L to 193.3 UI/L, in T1 group from 697 UI/L to 312 UI/L, and in T2 group from 453.7 UI/L to 263.6 UI/L. Mean ALT decreased in C group from 121.3 UI/L to 80.3 UI/L, in T1 group from 178.8 UI/L to 167.3 UI/L, and in T2 group from 124.8 UI/L to 120.2 UI/L(p=0.02). Mean total Cholesterol in C, T1, and T2 groups changed from 76.3,75.8, and 78.8 mg/dl to 80.8, 77, and 73.9 mg/dl, respectively (p=0.05). Mean serum TG in C, T1, and T2 groups decreased from 87.3, 128.1, and 133.7 mg/dl to 78, 58, and 89.3 mg/dl, respectively (P=0.02).Conclusion: All in all, the results indicated that the diet containing olive oil (10% and 20%) decreased the level of ALT enzyme and the diet with 20% olive oil reduced total serum cholesterol level in rats.References
Ferramosca A, Zara V. Modulation of hepatic steatosis by dietary fatty acids. World J Gastroenterol. 2014;20(7):1746-55.
Ahmed MH, Abu EO, Byrne CD. Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities? Primary care diabetes. 2010;4(3):129-37.
Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine. 2002;346(16):1221-31.
Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. Journal of gastroenterology and hepatology. 2005;20(2):229-33.
Sotoudehmanesh R, Sotoudeh M, Ali-Asgari A, Abedi-Ardakani B, Tavangar S-M, Khakinejad A, et al. Silent liver diseases in autopsies from forensic medicine of Tehran. Arch Iran Med. 2006;9(4):324-8.
Rogha M, Najafi N, Azari A, Kaji M, Pourmoghaddas Z, Rajabi F, et al. Non-alcoholic steatohepatitis in a sample of iranian adult population: age is a risk factor. International journal of preventive medicine. 2011;2(1).
Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. Journal of hepatology. 2008;49(4):608-12.
Parker HM, Johnson NA, Burdon CA, Cohn JS, O’Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Journal of hepatology. 2012;56(4):944-51.
Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. The Journal of clinical investigation. 2008;118(3):829-38.
Bahrololumi SS, Shidfar F, Jazaeri S. The effects of virgin olive oil-rich diet on anthropometric parameters and aminotransferases in non alcoholic fatty liver patients with weight loss diet. Razi Journal of Medical Sciences. 2014;20(116):66-77.
de Wit NJ, Afman LA, Mensink M, Müller M. Phenotyping the effect of diet on non-alcoholic fatty liver disease. Journal of hepatology. 2012;57(6):1370-3.
Martínez-González MÁ, Sánchez-Villegas A. Review: The emerging role of Mediterranean diets in cardiovascular epidemiology: Monounsaturated fats, olive oil, red wine or the whole pattern? European journal of epidemiology. 2004;19(1):9-13.
Nanda K. Non‐alcoholic steatohepatitis in children. Pediatric transplantation. 2004;8(6):613-8.
Roberts EA. Non-alcoholic fatty liver disease (NAFLD) in children. Front Biosci. 2005;10:2306-18.
Fraser A, Abel R, Lawlor D, Fraser D, Elhayany A. A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial. Diabetologia. 2008;51(9):1616-22.
Chatrath H VR, Chalasani N, editors. Dyslipidemia in patients with nonalcoholic fatty liver disease. Seminars in liver disease; 2012: Thieme Medical Publisher.
Hussein O GM, Lasri E, Svalb S, Ravid U, Assy N. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World journal of gastroenterology. 2007;13(3):361.
Hernández R M-LE, Cañuelo A, Del Moral ML, Blanco S, Siles E, et al. Steatosis recovery after treatment with a balanced sunflower or olive oil-based diet: involvement of perisinusoidal stellate cells. World journal of gastroenterology. 2005;11(47):7480.
1999;70(3):475s-90s LJHeovafamoaihesTAjocn.
Fitó M GM, Corella D, Sáez G, Estruch R, de la Torre R, et al. Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Archives of Internal Medicine. 2007;167(11):1195-203.
Sacks F. Consensus statement on dietary fat tMd, and lifelong good health. Am J Med. 2002;113:5S-8S.
Alonso A R-GV, Martínez-González MÁ. Monounsaturated fatty acids, olive oil and blood pressure: epidemiological, clinical and experimental evidence. Public health nutrition. 2006;9(02):251-7.
1998;67(3):577S-82S GAH-m-fdfpwdmam-aTAjocn.
Kris-Etherton PM HK, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. The American journal of medicine. 2002;113(9):71-88.
Beauchamp GK KR, Morel D, Lin J, Pika J, Han Q, et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005;437(7055):45-6.
Soriguer F EI, Rojo-Martinez G, De Adana MR, Dobarganes M, Garcia-Almeida J, et al. Oleic acid from cooking oils is associated with lower insulin resistance in the general population (Pizarra study). European journal of endocrinology. 2004;150(1):33-9.
Soriguer F MF, Rojo-Martinez G, Garcia-Fuentes E, Tinahones F, Gomez-Zumaquero J, et al. Monounsaturated n-9 fatty acids and adipocyte lipolysis in rats. British journal of nutrition. 2003;90(06):1015-22.
Assy N NF, Nasser G, Grosovski M. Olive oil consumption and non-alcoholic fatty liver disease. World journal of gastroenterology. 2009;15(15):1809-15.
Sato K AH, Mizuno A, Fukaya M, Sato T, Koganei M, et al. Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats. The Journal of nutrition. 2007;137(8):1908-15.
Covas M-I, Nyyssönen K, Poulsen HE, Kaikkonen J, Zunft H-JF, Kiesewetter H, et al. The effect of polyphenols in olive oil on heart disease risk factorsa randomized trial. Annals of internal medicine. 2006;145(5):333-41.
de la Puerta R GV, Hoult JRS. Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochemical pharmacology. 1999;57(4):445-9.
Fuentes F L-MJ, Sanchez E, Sanchez F, Paez J, Paz-Rojas E, et al. Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Annals of Internal Medicine. 2001;134(12):1115-9.
Esposito K MR, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Jama. 2004;292(12):1440-6.
Madigan C RM, Owens D, Collins P, Tomkin GH. Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes care. 2000;23(10):1472-7.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.
